Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Government Contract opportunity from Department Of Defense was posted on September 17, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Supply of Iohexol Injection, USP

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

This subcontract through the Department of Defense Medical Supply Chain Pharm FSA involves the sourcing and delivery of pharmaceutical-grade Iohexol Injection, USP. The requirement specifies the delivery of two boxes of 300mg/ml contrast agent contained in 150ml polymer bottles. All supplies must adhere to USP standards, DLA Packaging Requirement RP001, Technical/Quality Requirement RA001, and Medical Marking Standard No. 1. The provider must maintain a licensed pharmaceutical distribution capability and ensure full compliance with the Buy American Act. Performance for this contract is designated for FPO 09514, with the solicitation falling under NAICS code 339113.

General Info

DoD subcontract for sourcing and delivering USP pharmaceutical-grade Iohexol Injection to FPO 09514.

NAICS

339113 - Surgical Appliance and Supplies Manufacturing

Place of Performance

FPO, AE, 09514, USA

Set-Aside

NONE

Documents

This scope was carved out of SPE2DP-26-T-5149.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

IOHEXOL INJECTION

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supplies Iohexol Injection, USP for primes delivering DLA supply contracts. Sources and delivers 300mg/ml contrast agent in 150ml polymer bottles. Ensures compliance with USP standards, DLA Packaging Requirement RP001, Technical/Quality Requirement RA001, and Medical Marking Standard No. 1. Requires licensed pharmaceutical distribution and Buy American Act compliance. Delivers 2 boxes of pharmaceutical-grade Iohexol.

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS